INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)
Close on Nov 17, 2026Market cap $26.73BP/E –Yield –
Insmed total assets
Total assets on the balance sheet at the end of each period.
Insmed's total assets was $2.23B at Sep 30, 2026. For fiscal 2025 it was $2.26B, up 11.8% from the year before. Over ten years it grew 20.3% a year on average. The highest annual figure on record is $2.26B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | +11.8% |
| FY2024 | Dec 31, 2024 | $2.03B | +52.3% |
| FY2023 | Dec 31, 2023 | $1.33B | -19.7% |
| FY2022 | Dec 31, 2022 | $1.66B | +33.2% |
| FY2021 | Dec 31, 2021 | $1.24B | +56.2% |
| FY2020 | Dec 31, 2020 | $796.16M | +7.3% |
| FY2019 | Dec 31, 2019 | $742.30M | +22.8% |
| FY2018 | Dec 31, 2018 | $604.56M | +30.8% |
| FY2017 | Dec 31, 2017 | $462.05M | +94.2% |
| FY2016 | Dec 31, 2016 | $237.96M | -33.3% |
| FY2015 | Dec 31, 2015 | $356.56M | +54.4% |
| FY2014 | Dec 31, 2014 | $230.86M | +30.8% |
| FY2013 | Dec 31, 2013 | $176.50M | +14.9% |
| FY2012 | Dec 31, 2012 | $153.56M | +9.8% |
| FY2011 | Dec 31, 2011 | $139.83M | -28.8% |
| FY2010 | Dec 31, 2010 | $196.27M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.23B | -5.7% |
| Q2 FY2026 | Jun 30, 2026 | $2.10B | -15.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.08B | +15.2% |
| Q4 FY2025 | Dec 31, 2025 | $2.26B | +11.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.36B | +15.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.48B | +37.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.80B | +55.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.03B | +52.3% |
| Q3 FY2024 | Sep 30, 2024 | $2.05B | +55.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.81B | +25.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.16B | -23.6% |
| Q4 FY2023 | Dec 31, 2023 | $1.33B | -19.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.32B | +33.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.44B | +36.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.52B | +31.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.66B | +33.2% |
| Q3 FY2022 | Sep 30, 2022 | $994.82M | -24.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.05B | -14.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.15B | +66.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.24B | +56.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.31B | +56.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.23B | +38.9% |
| Q1 FY2021 | Mar 31, 2021 | $692.39M | +2.3% |
| Q4 FY2020 | Dec 31, 2020 | $796.16M | +7.3% |
| Q3 FY2020 | Sep 30, 2020 | $840.72M | +10.2% |
| Q2 FY2020 | Jun 30, 2020 | $885.37M | +10.3% |
| Q1 FY2020 | Mar 31, 2020 | $676.53M | +13.5% |
| Q4 FY2019 | Dec 31, 2019 | $742.30M | +22.8% |
| Q3 FY2019 | Sep 30, 2019 | $763.12M | +15.4% |
| Q2 FY2019 | Jun 30, 2019 | $802.78M | +10.8% |
| Q1 FY2019 | Mar 31, 2019 | $595.92M | -22.9% |
| Q4 FY2018 | Dec 31, 2018 | $604.56M | +30.8% |
| Q3 FY2018 | Sep 30, 2018 | $661.51M | +30.7% |
| Q2 FY2018 | Jun 30, 2018 | $724.24M | +337.2% |
| Q1 FY2018 | Mar 31, 2018 | $773.15M | +285.3% |
| Q4 FY2017 | Dec 31, 2017 | $462.05M | +94.2% |
| Q3 FY2017 | Sep 30, 2017 | $506.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $165.64M | – |
| Q1 FY2017 | Mar 31, 2017 | $200.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $237.96M | – |
See a number that looks wrong?